Industry News
Study details microRNA's role as a double agent during Hep C infection
3/17/2015
By coopting miRNA-122, the virus appears to alter gene expression in the liverWhen researchers looked at sites on liver cell genomes where the gene-regulating molecule miRNA-122 binds, they...
The origin of the lymphatic vasculature uncovered
3/17/2015
In a new study, published in Cell Reports, researchers at Uppsala University describe a novel mechanism by which lymphatic vessels form during embryonic development.
Skyrocketing cancer drug costs 'are damaging patient care'
3/16/2015
In an article published in Mayo Clinic Proceedings, oncologists make recommendations on how to curb the rapidly escalating costs of cancer drugs in the US.
Gene mutations may predict melanoma response to immunotherapies
3/16/2015
Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center...
Advanced screening test to improve European colorectal cancer survival rates
3/16/2015
Colorectal cancer is the most common type of GI cancer in Europe, with 342,137 new cases recorded in the EU in 2012.
Stomach cancer is diagnosed in around 80,000 people in the European Union (EU) each year1 and is associated with a very poor prognosis.
Nodal alone does not produce anti-cancer effects
3/16/2015
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened.
Genetically engineered immunotoxin shows early promise in patients with B-cell malignancies
3/16/2015
Almost all patients with a group of blood cancers called B-cell malignancies have two prominent "fingerprints" on the surface of leukemia and lymphoma cancers, called CD22 and CD19, Vallera explained.
New genome-editing technology to help treat blood cancers
3/16/2015
Melbourne researchers have developed a new genome editing technology that can target and kill blood cancer cells with high accuracy.
Regeneration in a hostile environment
3/16/2015
Cancer drug promotes regeneration of damaged neuronsImmunostaining shows axons (red), synapses (green), and motor neurons (blue).